Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 701–800 of 1,001
Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats
Kwong, J. M. K., & Caprioli, J. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.017 · Cited by 45
Gangnuss, S., Cowin, A. J., Daehn, I. S., Hatzirodos, N., Rothnagel, J. A., Varelias, A., & Rayner, T. E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22319.x · Cited by 48
Activation of ERK and JNK signaling pathways by mycotoxin citrinin in human cells
Chang, C.-H., Yu, F., Wang, L., Lin, Y.-S., & Liu, B.-H. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.021 · Cited by 50
Signaling from Polyomavirus Middle T and Small T Defines Different Roles for Protein Phosphatase 2A
Mullane, K. P., Ratnofsky, M., Culleré, X., & Schaffhausen, B. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7556 · Cited by 50
“A number of studies have implicated jnk in signaling in response to cytokines or to cell stress (46, 100).”
BackgroundRecombinant TCR Ligand Induces Early TCR Signaling and a Unique Pattern of Downstream Activation
Wang, C., Mooney, J. L., Meza‐Romero, R., Chou, Y. K., Huan, J., Vandenbark, A. A., Offner, H., & Burrows, G. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1934 · Cited by 44
“of ERKs leads to the formation of the AP-1 complex (30), which”
BackgroundAsbestos induces activator protein-1 transactivation in transgenic mice.
Ding, M., Dong, Z., Chen, F., Pack, D., Ma, W. Y., Ye, J., Shi, X., Castranova, V., & Vallyathan, V. (1999) · PubMed · Cited by 51
Resveratrol stimulates AP ‐1‐regulated gene transcription
Thiel, G., & Rößler, O. G. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300913 · Cited by 44
ERK1 plays a critical protective role against N‐methyl‐D‐aspartate‐induced retinal injury
Nakazawa, T., Shimura, M., Ryu, M., Nishida, K., Pagès, G., Pouysségur, J., & Endo, S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21472 · Cited by 43
García-Lastra, R., San‐Miguel, B., Crespo, I., Jorquera, F., Alvarez, M., González‐Gallego, J., & Tuñón, M. J. (2009) · Veterinary Research · doi:10.1051/vetres/2009050 · Cited by 46
“Moreover, in many cell types, whereas ERK1/2 generally inhibits apoptotic processes, JNK and p38 MAPK contribute to the induction of apoptosis [49].”
BackgroundLi, Y., Jiang, Z., Xue, D., Deng, G., Li, M., Liu, X., & Wang, Y. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0842-0 · Cited by 44
“These enzymes can be activated through phosphorylation by different extracellular irritants, such as mitogen, growth factors and oxidative stress [33].”
Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases
Yue, T., Ohlstein, E. H., & Ruffolo, R. R., Jr. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80069-6 · Cited by 43
Eynott, P. R., Xu, L., Bennett, B. L., Noble, A., Leung, S., Nath, P., Groneberg, D. A., Adcock, I. M., & Chung, K. F. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01887.x · Cited by 46
Han, E. H., Kim, J. Y., Kim, H.-K., Hwang, Y. P., & Jeong, H. G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.003 · Cited by 43
“Various growth and differentiation factors induce the ERK pathway, whereas the JNK and p38 pathways are commonly involved in stressmediated signaling (Whitmarsh and Davis, 1996).”
BackgroundMesenchymal miR-21 regulates branching morphogenesis in murine submandibular gland in vitro
Hayashi, T., Koyama, N., Azuma, Y., & Kashimata, M. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.01.030 · Cited by 49
“Furthermore, AP-1 is one of the major downstream effectors for mitogen-activated protein kinase (MAPK), and it is known that EGF activates the MAPK pathway (Kashimata and Gresik, 1997; Kajanne et al., 2007; Prenzel et al., 2001; Yarden and Sliwkowski, 2001; Whitmarsh and Davis, 1996).”
Ocker, M., Herold, C., Ganslmayer, M., Hahn, E. G., & Schuppan, D. (2003) · International Journal of Cancer · doi:10.1002/ijc.11410 · Cited by 43
Hisatsune, J., Yamasaki, E., Nakayama, M., Shirasaka, D., Kurazono, H., Katagata, Y., Inoue, H., Han, J., Sap, J., Yahiro, K., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00500-07 · Cited by 54
“Among known positive COX-2 VOL. 75, 2007 ENHANCEMENT OF PGE2 PRODUCTION BY VacA 4475 transcriptional regulators, such as NF- B (41), NF–interleukin-6 (NF–IL-6) (41), AP-1 (41), NFAT (17), or ATF-2/CREB (38), we found that VacA induced activation of ATF-2 through p38 MAP kinase stimulation in AZ-521 cells (33).”
BackgroundJibiki, I., Hashimoto, S., Maruoka, S., Gon, Y., Matsuzawa, A., Nishitoh, H., Ichijo, H., & Horie, T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2204042 · Cited by 43
Kim, Y., Chongviriyaphan, N., Liu, C., Russell, R. M., & Wang, X.-D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi340 · Cited by 51
PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells
Leyton, J., Gozes, Y., Pisegna, J. R., Coy, D. H., Purdom, S., Casibang, M., Zia, F. Z., & Moody, T. W. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006262611290 · Cited by 43
“binding element, the serum response binding element, and/or the sis inducible element, altering nuclear oncogene expression [ 40 ].”
Jyonouchi, H., Sun, S., Iijima, K., Wang, M., & Hecht, S. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.139 · Cited by 43
Angiotensin II type 1 receptor-modulated signaling pathways in neurons
Richards, E. M., Raizada, M. K., Gelband, C. H., & Sumners, C. (1999) · Molecular Neurobiology · doi:10.1007/bf02741376 · Cited by 49
“The mechanisms have not yet been elucidated in these cells, but probably involve phosphorylation of Elk-1 in preformed, DNA bound ternary complexes on the c-los serum response element (SRE) ( 56 ).”
Rice, D., Dobrian, A. D., Schriver, S. D., & Prewitt, R. L. (2002) · Hypertension · doi:10.1161/hy0202.102834 · Cited by 43
Li, X., Yu, H., Graves, L. M., & Earp, H. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14996 · Cited by 44
Garofalo, M., Payros, D., Taieb, F. E., Oswald, É., Nougayrède, J., & Oswald, I. P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2271101 · Cited by 45
“…of apoptosis through MAPK can be explained by their ability to increase the expression of pro-apoptotic factors: MAPK was shown to increase the expression of transcription factors, such as p53 or AP-1, resulting in the production of pro-apoptotic proteins (Whitmarsh and Davis 1996; Wu 2004).”
A multi-omic analysis of human naïve CD4+ T cells
Mitchell, C. J., Getnet, D., Kim, M., Manda, S. S., Kumar, P., Huang, T., Pinto, S. M., Nirujogi, R. S., Iwasaki, M., Shaw, P. G., et al. (2015) · BMC Systems Biology · doi:10.1186/s12918-015-0225-4 · Cited by 51
“This is particularly interesting considering that MAP2K3 is involved in the activation of p38-MAPK, which in turn has been shown to promote transcription of multiple genes involved in cell cycle regulation and apoptosis such as p53 and MYC [11, 12].”
BackgroundMiyazaki, H., Morishita, J., Ueki, M., Nishina, K., Shiozawa, S., & Nobuhiro Maekawa, A. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-153 · Cited by 42
“The responses to LPS are mostly dependent on the mitogen-activated protein kinase (MAPK) pathways and activation of MAPK by dual phosphorylation can enhance the transcriptional activity of activator protein (AP)-1 [4].”
BackgroundKyosseva, S. V. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.017 · Cited by 45
“The Fos (c-Fos and Fos B), as well as the Fos-related antigens (Fra 1 and Fra 2) and Jun (c-Jun, Jun B and Jun D) families of proteins, which heterodimerize to form the activator protein (AP)-1 complex (Whitmarsh and Davis, 1996), is presented in the promoter region of certain neuronal genes that encode neuropeptides…”
BackgroundMechanism of IFN-β-Mediated Inhibition of IL-8 Gene Expression in Astroglioma Cells
Nozell, S. E., Laver, T., Patel, K. D., & Benveniste, E. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.822 · Cited by 44
“Unlike NF- B and C/EBP , which require cytoplasmic activation, AP-1 proteins are usually bound to their response elements and are regulated by their abundance and posttranslational modifications (33, 34).”
BackgroundZhang, H. Y., Zhang, X., Chen, X., Thomas, D., Hormi-Carver, K. K., Elder, F. F. B., Spechler, S. J., & Souza, R. F. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90262.2008 · Cited by 43
“The best characterized MAPK signaling pathway is the Ras-Raf-MEK-ERK cascade (9, 30).”
BackgroundAltered oxidative stress response of the long-lived Snell dwarf mouse
Madsen, M. A., Hsieh, C.-C., Boylston, W. H., Flurkey, K., Harrison, D., & Papaconstantinou, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.126 · Cited by 42
“Elk-1 is of particular interest since our data show wild type mice have over 10 times more Elk-1 protein than dwarf mice (Fig.”
BackgroundInfluentialZhou, Y., Millward-Sadler, S. J., Lin, H., Robinson, H. H., Goldring, M. B., Salter, D. M., & Nuki, G. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.02.001 · Cited by 42
Orlov, S. N., Taurin, S., Thorin‐Trescases, N., Dulin, N. O., Tremblay, J., & Hamet, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1062 · Cited by 42
Shan, R., Price, J. O., Gaarde, W. A., Monia, B. P., Krantz, S. B., & Zhao, Z. J. (1999) · Blood · doi:10.1182/blood.v94.12.4067 · Cited by 44
RetractedLhuillier, L., & Dryer, S. E. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05616.2000 · Cited by 42
“Here we show that a single 3 hr exposure to TGFb1 can also induce long-lasting stimulation of macroscopic KCa that persists for at least 3.5 d after the end of the treatment.”
BackgroundInfluentialZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP‐1‐dependent manner
Yang, J., Lee, Y., Hung, H., Tseng, W., Tu, C., Lee, H., & Wu, W. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01537.x · Cited by 41
Carotenuto, Y., Dattolo, E., Lauritano, C., Pisano, F., Sanges, R., Miralto, A., Procaccini, G., & Ianora, A. (2013) · Harmful Algae · doi:10.1016/j.hal.2013.11.002 · Cited by 46
Wang, Q., Luo, W., Zhang, W., Dai, Z., Chen, Y., & Chen, J. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.04.004 · Cited by 43
“Signaling through theMAPK pathways culminates in the phosphorylation-dependent activation of a variety of transcription factors that modulate cytokine gene expression (Su and Karin, 1996; Treisman, 1996; Whitmarsh and Davis, 1996).”
BackgroundLi, C., Shi, L., Wang, Y., Peng, C., Wu, L., Zhang, Y., & Du, Z. (2021) · Environmental Toxicology · doi:10.1002/tox.23137 · Cited by 44
“Phosphorylation of JNK can promote the formation of its transcription factor c-Jun, and c-Jun can bind to the transcriptional activation protein-1 (AP-1) site of many genes in the posterior region.(56) The MMP-9 promoter contains AP-1 sites, and studies have shown that reducing AP-1 can significantly inhibit the expre…”
BackgroundJoetham, A., Ohnishi, H., Okamoto, M., Takeda, K., Schedel, M., Domenico, J. M., Dakhama, A., & Gelfand, E. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316943 · Cited by 42
“Upon activation, JNK phosphorylates a number of downstream targets, including c-Jun, which heterodimerizes with Fos to form the transcription factor activator protein 1 (35).”
BackgroundShin, S. Y., Kim, C. G., Lim, Y., & Lee, Y. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216721 · Cited by 46
Induction of MMP-10 and MMP-1 in a squamous cell carcinoma cell line by ultraviolet radiation
Ramos, M. C., Steinbrenner, H., Stuhlmann, D., Sies, H., & Brenneisen, P. (2004) · Biological Chemistry · doi:10.1515/bc.2004.010 · Cited by 41
“Some of the targets of MAPK are the proteins c-fos and c-jun, forming the transcription factor complex AP-1 (Whitmarsh and Davis, 1996).”
BackgroundYamada, S., Ding, Y., Tanimoto, A., Wang, K., Guo, X., Li, Z., Tasaki, T., Nabeshima, A., Murata, Y., Shimajiri, S., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227140 · Cited by 41
Isolation and characterization of the promoter region of the human GM3 synthase gene
Kim, S.-W., Lee, S., Kim, K.-S., Kim, C., Choo, Y., & Lee, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00505-5 · Cited by 41
Adiseshaiah, P. P., Papaiahgari, S. R., Vuong, H., Kalvakolanu, D. V., & Reddy, S. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303505200 · Cited by 44
Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway
Lim, J. Y., Kim, H., Kim, Y. H., Kim, S. W., Huh, P., Lee, K.-H., Jeun, S., Rha, H. K., & Kang, J. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00124-4 · Cited by 44
Kim, J. M., Kim, N. I., Oh, Y., Kim, Y.-J., Youn, J., & Ahn, M. (2005) · International Immunology · doi:10.1093/intimm/dxh345 · Cited by 40
“AP-1 activation is known to induce the expression of IL-8 ( 23 ).”
BackgroundWeizman, N., Shiloh, Y., & Barzilai, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211168200 · Cited by 43
Hafez, M., Hayes, K., Goldrick, M., Grencis, R. K., & Roberts, I. S. (2010) · Infection and Immunity · doi:10.1128/iai.01406-09 · Cited by 43
“In the case of the AP-1-mediated pathway, activation of AP-1 is preceded by the mitogen-activated protein kinase (MAPK) activation pathway (29, 58).”
BackgroundInfluentialNarayanan, K., Srinivas, R., Peterson, M. C., Ramachandran, A., Hao, J. J., Thimmapaya, B., Scherer, P. E., & George, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403511200 · Cited by 45
Gesser, B., Rasmussen, M. K., Raaby, L., Rosada, C., Johansen, C., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2011) · Inflammation Research · doi:10.1007/s00011-011-0316-7 · Cited by 44
“because ERK activation regulates cell proliferation through the expression of c-Fos [28, 29], we next investigated the effect of DMF on MIF-induced c-Jun, JunB and c-Fos”
BackgroundMethodAccent]n, C. H. A., Elsheikh, E. B., Christensson, M., Liu, J., Johansson, A., Qureshi, A. R., Jalkanen, S., & Sumitran–Holgersson, S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006111286 · Cited by 40
Luo, S., Kang, H., Kong, J.-R., Xie, R.-C., Liu, Y., Wang, W.-N., Xie, F., Wang, C., & Sun, Z. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.06.003 · Cited by 41
“In addition, there is a large volume of published studies describing a regulatory role of MAPK/ERK signaling involved in AP-1 activation (Whitmarsh and Davis, 1996).”
BackgroundGuo, L., Guo, Y., Xiao, S., & Shi, X. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.03.019 · Cited by 41
Lee, S. H., Seo, G. S., Kim, H. S., Woo, S. W., Ko, G., & Sohn, D. H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.004 · Cited by 40
Li, X., Qiu, J., Wang, J., Zhong, Y., Zhu, J., & Chen, Y. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02254-2 · Cited by 41
Conrad, P., Millhorn, D. E., & Beitner‐Johnson, D. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_28 · Cited by 48
Misra, U. K., Gawdi, G., Gonzalez-Gronow, M., & Pizzo, S. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25785 · Cited by 42
Effects of Ethanol and Its Metabolites on Human Pancreatic Stellate Cells
Masamune, A., Satoh, A., Watanabe, T., Kikuta, K., Satoh, M., Suzuki, N., Satoh, K., & Shimosegawa, T. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0695-y · Cited by 39
“Induction of the expression of AP-1 components c-Fos and c-Jun by a variety of stimuli such as growth factors and cytokines is mediated by the activation of three distinct MAP kinases: ERK, JNK, and p38 MAP kinase [26].”
BackgroundZhu, B., & Wu, X. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.02.026 · Cited by 42
“MAPK kinases almost exist in all eukaryotic cells and have been implicated in the induction of inflammatory responses and the regulation of cell growth and differention (Whitmarsh and Davis, 1996).”
Backgroundvan der Westhuizen, E. T., Christopoulos, A., Sexton, P. M., Wade, J. D., & Summers, R. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061432 · Cited by 39
“It is known that gene transcription from AP-1 sites may occur downstream of the p38 MAPK, JNK, ERK1/2, or ERK5 signaling pathways (Price et al., 1996; Whitmarsh and Davis, 1996; Roux and Blenis, 2004).”
BackgroundSaadane, A., Eastman, J. F., Berger, M., & Bonfield, T. L. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-26 · Cited by 39
“Because AP-1 is activated by mitogen-activated protein kinases (MAPKs) [17,26,27], we sought to determine whether activation of these enzymes might be associated with AP-1 activation in the CF cells.”
BackgroundXenobiotic-induced TNF-α expression and apoptosis through the p38 MAPK signaling pathway
Frigo, D. E., Vigh, K. A., Struckhoff, A. P., Elliott, S. G., Beckman, B. S., Burow, M. E., & McLachlan, J. A. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.09.008 · Cited by 39
Vallejo, J. G., Knuefermann, P., Mann, D. L., & Sivasubramanian, N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.419 · Cited by 39
“In agreement with previous reports indicating that p38 MAPK is required for the activation of several transcription factors, including cAMP response element-binding protein (30), c-Fos, and c-Jun (21), we have shown that GBS induction of AP-1 requires activation of the p38 MAPK pathway.”
BackgroundResultHochholdinger, F., Baier, G., Nogalo, A., Bauer, B., Grunicke, H. H., & Überall, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8052 · Cited by 44
Ordan, O., Rotem, R., Jaspers, I., & Flescher, E. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705163 · Cited by 39
“The downstream effects of JNK include activation of protein kinases and transcription factors, including AP-1 (Whitmarsh & Davis, 1996).”
BackgroundActivation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells
Bernal‐Mizrachi, E., Wu, W., Srinivasan, S., Klenk, A. S., Cohen, D., & Permutt, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1286 · Cited by 39
Ahmadi, P., Doyle, D., Mojarad, N., Taherkhani, S., Janzadeh, A., Honardoost, M., & Gholami, M. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2500546 · Cited by 46
“(Whitmarsh and Davis 1996; McCubrey et al. 2006; Rezatabar et al. 2019).”
Turner, M. D., Chaudhry, A., & Nedjai, B. (2011) · Bioscience Reports · doi:10.1042/bsr20110089 · Cited by 45
Ovarian metabolism of xenobiotics
Bhattacharya, P., & Keating, A. F. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011051 · Cited by 41
Sun, J., Wang, L., Wu, Z., Han, S., Wang, L., Li, M., Liu, Z., & Song, L. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.10.011 · Cited by 40
Bae, G., Kim, J., Park, K., Koo, B. S., Jo, I., Choi, S.-B., Lee, C. H., Jung, W., Cho, J., Hong, S., et al. (2012) · Phytotherapy Research · doi:10.1002/ptr.4649 · Cited by 38
Dössel, J., Meyer‐Hoffert, U., Schröder, J., & Gerstel, U. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01801.x · Cited by 46
“As a result, PKCs can induce several intracellular regulators as ERK1/2, mitogen-activated protein kinase (MAPK), AP-1 and NFkB (Whitmarsh and Davis, 1996; Ratner et al., 2001; Adamo et al., 2004; Ramos et al., 2004).”
BackgroundInfluentialMurine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity
Anguíta, J., Barthold, S. W., Persinski, R., Hedrick, M. N., Huy, C. A., Davis, R. J., Flavell, R. A., & Fikrig, E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6352 · Cited by 38
“Several parallel MAP kinase signal transduction pathways that are functionally independent have been defined in mammalian cells (35, 36), including the extracellular signal-regulated kinase (37, 38), c-Jun amino-terminal kinases (also known as stress-activated protein kinases) (39, 40), and p38 MAP kinase (41–43).”
BackgroundSelf-citationSLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells
Iacopetta, D., Lappano, R., Cappello, A. R., Madeo, M., Francesco, E. M. D., Santoro, A., Curcio, R., Capobianco, L., Pezzi, V., Maggiolini, M., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0620-x · Cited by 40
“Analysing the SLC37A1 promoter sequence, we identified seven AP-1 sites, which may represent the principal targets of growth factors and hormone signaling pathways [ 35 ].”
BackgroundWu, J., Suzuki, H., Akhand, A. A., Zhou, Y., Hossain, K., & Nakashima, I. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00278-9 · Cited by 40
Kendal‐Wright, C. E., & Bryant-Greenwood, G. D. (2006) · Placenta · doi:10.1016/j.placenta.2006.03.011 · Cited by 38
TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection
Dey, N., Liu, T., Garofalo, R. P., & Casola, A. (2011) · Virology · doi:10.1016/j.virol.2011.07.007 · Cited by 42
“Regulation of AP-1 activation occurs at the level of its expression, as well as through post-translational modifications, specifically phosphorylation by the c-jun N-terminal kinase (JNK), which belongs to the mitogenactivated protein kinase family (MAPKs), resulting in increased transactivation potential of AP-1 (Kar…”
Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation
Chu, S., & Ferro, T. J. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00454.2005 · Cited by 42
“A classic example is the phosphorylation and activation of activator protein-1 (AP-1) when JNK is activated during inflammation (22, 44).”
BackgroundYue, J., Sun, B., Liu, G., & Mulder, K. M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10469 · Cited by 38
Samet, J. M., Silbajoris, R. A., Huang, T., & Jaspers, I. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110985 · Cited by 38
“c-Jun is a component of the AP-1 heterodimer that binds to the ternary complex response element/AP-1 DNA response element (48).”
Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein.
Henkler, F., Jones, M., Koshy, R., & Lopes, A. R. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-11-2737 · Cited by 38
“The JNK pathway [also called SAPK (stress activated protein kinase)] is particularly associated with transduction of stress-related signals (Kyriakis et al., 1994; Sanchez et al., 1994; Whitmarsh & Davis, 1996 ), but can also activate Erk in tissue culture.”
BackgroundMethodInfluentialEnvironmental Stressors in Health and Disease
Fuchs, J. (2001) · CRC Press eBooks · doi:10.1201/9780203904787 · Cited by 40
Effects of Heavy Metals on Mitogen-Activated Protein Kinase Pathways.
Matsuoka, M., & Igisu, H. (2002) · Environmental Health and Preventive Medicine · doi:10.1007/bf02897972 · Cited by 39
Immunological synapse: a multi‐protein signalling cellular apparatus for controlling gene expression
Padhan, K., & Varma, R. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03241.x · Cited by 42
p38 Mitogen-Activated Protein Kinase and Hematologic Malignancies
Feng, Y., Wen, J., & Chang, C.-C. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.11.1850 · Cited by 46
Lee, S., & Schorey, J. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6499-6507.2005 · Cited by 44
“The transcriptional activity of c-jun required JNK, while CREB and ATF-2 were dependent on JNK or p38 activation (20, 30).”
BackgroundKinoshita, I., Leaner, V. D., Katabami, M., Manzano, R. G., Dent, P., Sabichi, A. L., & Birrer, M. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206371 · Cited by 40
“Many extracellular stimuli rapidly activate and induce cJun through well-characterized cytoplasmic signaling cascades to presumably activate cJun target gene transcription (Karin, 1996; Liu et al., 1996; Whitmarsh and Davis, 1996).”
BackgroundMercer, K., Giblett, S. M., Oakden, A., Brown, J., Marais, R., & Pritchard, C. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208707 · Cited by 37
“…are able to phosphorylate transcription factors, particularly the AP-1 complex that comprises various heterodimers of c-fos (c-fos, FosB, Fra-1, Fra-2) and c-jun (c-Jun, JunB, JunD) family members (Whitmarsh and Davis, 1996; Balmanno and Cook, 1999; Cook et al., 1999; Shaulian and Karin, 2002).”
BackgroundMeijer, L. K., Schesser, K., Wolf‐Watz, H., Sassone‐Corsi, P., & Pettersson, S. (2000) · Cellular Microbiology · doi:10.1046/j.1462-5822.2000.00049.x · Cited by 37
“production as well as in the regulation of cell growth and differentiation (Whitmarsh and Davis, 1996; Ip and Davis, 1998).”
BackgroundPintucci, G., Steinberg, B. M., Seghezzi, G., Yun, J., Apazidis, A., Baumann, F. G., Grossi, E. A., Colvin, S. B., Mignatti, P., & Galloway, A. C. (1999) · Surgery · doi:10.1016/s0039-6060(99)70187-x · Cited by 37
Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway
Ju, A., Cho, Y.-C., Kim, B. R., Park, S. G., Kim, J., Kim, K., Lee, J., Park, B. C., & Cho, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164259 · Cited by 37
Matsuda, N., Horikawa, M., Watanabe, M., Kitagawa, S., Kudo, Y., & Takata, T. (2002) · European Journal Of Oral Sciences · doi:10.1034/j.1600-0722.2002.21340.x · Cited by 36
ERIKSSON, M., Arminen, L., Karjalainen‐Lindsberg, M., & Leppä, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.017 · Cited by 42
Κογκοπούλου, Ό., Tzakos, E., Mavrothalassitis, G., Baldari, C. T., Paliogianni, F., Young, H. A., & Thyphronitis, G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705418 · Cited by 36
“Recent studies demonstrated that Erk mediates its activity on IL-2 through its main target, Elk-1, which up-regulates transcription of the AP-1 component c-Fos [8].”
BackgroundChuang, S., & Yang, J. (2001) · Springer eBooks · doi:10.1007/978-1-4615-0793-2_11 · Cited by 36
The Effect of Enteric-Derived Lipopolysaccharides on Obesity
Wang, K., Lai, W., Min, T., Wei, J., Bai, Y., Cao, H., Guo, J., & Su, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084305 · Cited by 43
“For example, the induction of intestinal flora imbalance by LPS exhibits more pronounced intestinal damage and an increased expression of β -defensins and Muc2.”
BackgroundWang, Y.-H., Chiu, W., Wang, Y.-K., Wu, C.-C., Chen, T.-L., Teng, C., Chang, W., Chang, H., & Tang, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604801200 · Cited by 36
Wang, Y., Fu, X., Xu, J., Wang, Q., & Kuang, H. (2016) · Scientific Reports · doi:10.1038/srep28089 · Cited by 35
Patel, S. S., Beshay, V. E., Escobar, J. C., Suzuki, T., & Carr, B. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1341 · Cited by 39
Wang, J., Tang, W., Yang, Z., Wan, J., Shi, L., Zhang, Y., Zhou, R., Ni, J., Hou, L., Zhou, Y., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.092 · Cited by 37
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.